Efficacy of Targeted Treatment Beyond Third-Line Therapy in Metastatic Kidney Cancer: Retrospective Analysis From a Large-Volume Cancer Center-Reference-Cited by-同舟云学术

Efficacy of Targeted Treatment Beyond Third-Line Therapy in Metastatic Kidney Cancer: Retrospective Analysis From a Large-Volume Cancer Center

Published:2015-06 Issue:3 Volume:13 Page:e145-e152
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Vallet Sonia^ORCID,Pahernik Sascha,Höfner Thomas,Tosev Georgi,Hadaschik Boris,Duensing Stefan,Sedlaczek Oliver,Hohenfellner Markus,Jäger Dirk,Grüllich Carsten

Funder

German Cancer Research Center (DKFZ)

German Cancer Aid (Deutsche Krebshilfe)

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference29 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009

3. Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the International Kidney Cancer Working Group;Manola;Clin Cancer Res,2011

4. Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC);Motzer;J Clin Oncol,2013

5. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial;Motzer;Lancet,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia Signaling in Cancer: From Basics to Clinical Practice;Pathology and Oncology Research;2021-05-03

2. ZALECENIA POSTĘPOWANIA DIAGNOSTYCZNO-TERAPEUTYCZNEGO W RAKU NERKOWOKOMÓRKOWYM;Oncology in Clinical Practice;2021-01-12

3. A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma;World Journal of Surgical Oncology;2020-10-22

4. Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL;Future Science OA;2018-06-01

5. Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)1;Kidney Cancer;2018-03-30